News & Views
Explore our latest news and insights as we move forward together.
Recent news
Norroy Bioscience Showcased Integrated Radiopharmaceutical Solutions at EANM 2025
Recent news
Norroy Bioscience Presents Promising Renal Cancer Imaging Data at 2025 ASCO Annual Meeting
Recent news
Norroy Showcased Three Oral Presentations at SNMMI 2025, Unveiling Next-Generation Radiopharmaceuticals for Renal Cancer and Beyond
News & View
-
JNM: Norroy Announces First-in-Human Clinical Results of Second-Generation Small-Molecule Radiopharmaceutical for Kidney Cancer
Read More -
Norroy's Kidney Cancer Radiopharmaceutical 18F-NYM005 Receives IND Approval from the U.S. FDA
Read More -
Norroy Bioscience Receives FDA Clearance for IND Applications of Two Proprietary Radiopharmaceuticals Targeting Prostate Cancer
Read More
